Transaction Details

Footnotes

Each restricted stock unit represents a contingent right to receive one share of common stock of ESAB Corporation. | Represents shares withheld by ESAB Corporation in connection with net share settlement to satisfy the reporting person's tax liability based upon the vesting of restricted stock units. No shares were sold by the reporting person to satisfy this tax liability. | Represents shares vested pursuant to performance-based restricted stock units granted on May 12, 2022, which vesting was subject to the certification of certain performance criteria. The award vested on May 12, 2025. | Represents shares withheld by ESAB Corporation in connection with net share settlement to satisfy the reporting person's tax liability based upon the vesting of performance-based restricted stock units. No shares were sold by the reporting person to satisfy this tax liability. | Represents shares withheld by ESAB Corporation in connection with net share settlement to satisfy the tax liability and exercise price associated with the reporting person's exercise of employee stock options. No shares were sold by the reporting person to satisfy the exercise price or this tax liability. | The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the reporting person. | This award represents restricted stock units that vest in three equal annual installments beginning on the first anniversary of the grant date. All remaining restricted stock units from this award vested on May 12, 2025. | This award represents restricted stock units that vest in three equal annual installments beginning on the third anniversary of the grant date. The remaining restricted stock units from this award will vest in two equal tranches on May 12, 2026 and May 12, 2027. | This award represents options that vested in three equal annual installments beginning on the first anniversary of the grant date. 7,334 options were fully vested and exercisable as of the date of ESAB Corporation's separation from Colfax Corporation. All remaining options became fully vested and exercisable on February 24, 2023.